CliffBio
small molecule

MORPHINE SULFATE

MORPHINE SULFATE

Loss of exclusivityMarch 2034latest FDA-listed patent expiry
CompanyFresenius Kabi →View the full company profile on CliffBio

Drug detail

Brand nameMORPHINE SULFATE
Active ingredientMORPHINE SULFATE
Strength2MG/ML (2MG/ML)
Dosage formSOLUTION
RouteINTRAMUSCULAR, INTRAVENOUS
ModalitySmall molecule
FDA approvalOctober 2013
Marketing statusRX

Listed patents

PatentExpiresType
9192608March 2034use U-55
9248229March 2034product
9072781March 2034product

More from Fresenius Kabi

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

MORPHINE SULFATE patent cliff — loss of exclusivity March 2034 | CliffBio